A detailed history of Relyea Zuckerberg Hanson LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Relyea Zuckerberg Hanson LLC holds 11,318 shares of AMRN stock, worth $4,979. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,318
Previous 11,318 -0.0%
Holding current value
$4,979
Previous $7,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 17, 2023

SELL
$1.12 - $1.49 $1,784 - $2,373
-1,593 Reduced 12.34%
11,318 $13,000
Q4 2022

Jan 18, 2023

BUY
$1.07 - $1.34 $1,704 - $2,134
1,593 Added 14.07%
12,911 $0
Q3 2022

Nov 02, 2022

SELL
$1.09 - $1.67 $521 - $798
-478 Reduced 4.05%
11,318 $12,000
Q2 2022

Jul 18, 2022

BUY
$1.13 - $3.69 $540 - $1,763
478 Added 4.22%
11,796 $18,000
Q4 2019

Jan 15, 2020

BUY
$13.94 - $24.12 $157,772 - $272,990
11,318 New
11,318 $243,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Relyea Zuckerberg Hanson LLC Portfolio

Follow Relyea Zuckerberg Hanson LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Relyea Zuckerberg Hanson LLC, based on Form 13F filings with the SEC.

News

Stay updated on Relyea Zuckerberg Hanson LLC with notifications on news.